The effectiveness of the central non-opioid analgesic nefopam in the treatment of acute pain syndrome in participants of a special military operation.

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

The goal is to evaluate the effectiveness and safety of the use of nefopam in the provision of medical care. The study of the effectiveness of nefopam was carried out in 2 groups: the 1st group (n=53) included patients who, because of dissatisfaction with analgesia, were additionally prescribed a non-steroidal anti-inflammatory drug and trimeperidine at a dose of 20 mg within 30 minutes after the administration of nefopam; Group 2 (n=201) received only nefopam. The administration of nefopam was accompanied by a decrease in pain intensity, normalization of heart rate, and respiratory movements in all 254 patients. The reason for the ineffective relief of pain in group 1 was the development of an initially severe pain syndrome. The likelihood of developing side effects (nausea, vomiting, tremors, sweating, subcutaneous erythema) was 2–9 times lower in group 2. Nefopam is recommended for the relief of pain of moderate intensity; its effectiveness for the relief of severe pain is insufficient.

Full Text

Restricted Access

About the authors

A. A. Sergoventsev

Main Military Medical Directorate of the Russian Defense Ministry

Email: vmeda-na@mil.ru

заслуженный врач РФ, кандидат медицинских наук, генерал-майор медицинской службы

Russian Federation, Moscow

A. V. Shchegolev

The S.M.Kirov Military Medical Academy of the Ministry of Defense of the Russian Federation

Email: vmeda-na@mil.ru

профессор, полковник медицинской службы

Russian Federation, St. Petersburg

A. P. Chuprina

Main Military Medical Directorate of the Russian Defense Ministry

Email: vmeda-na@mil.ru

доцент, полковник медицинской службы

Russian Federation, Moscow

A. N. Gritsai

The S.M.Kirov Military Medical Academy of the Ministry of Defense of the Russian Federation

Author for correspondence.
Email: vmeda-na@mil.ru

кандидат медицинских наук, полковник медицинской службы

Russian Federation, St. Petersburg

L. V. Arsentiev

The S.M.Kirov Military Medical Academy of the Ministry of Defense of the Russian Federation

Email: vmeda-na@mil.ru

кандидат медицинских наук, подполковник медицинской службы

Russian Federation, St. Petersburg

D. I. Aksenfeld

1602nd Military Clinical Hospital of the Russian Defense Ministry

Email: vmeda-na@mil.ru

подполковник медицинской службы

Russian Federation, Rostov-on-Don

E. A. Usoltsev

442nd Military Clinical Hospital of the Russian Defense Ministry

Email: vmeda-na@mil.ru

подполковник медицинской службы

Russian Federation, St. Petersburg

G. S. Soloviev

1472nd Naval Clinical Hospital of the Russian Defense Ministry

Email: vmeda-na@mil.ru

подполковник медицинской служб

Russian Federation, Sevastopol

References

  1. Абузарова Г.Р., Невзорова Д.В., Кумирова Э.В. и др. Обезболивание взрослых и детей при оказании медицинской помощи: Метод. реком. – М.: РНИМУ им. Н.И.Пирогова, 2016. – 94 с.
  2. Арбух Д.М., Абузарова Г.Р., Алексеева Г.С. Опиоидные анальгетики в терапии болевых синдромов (часть 1) // Вестн. анестезиол. и реаниматол. – 2017. – Т. 14, № 3. – С. 58–67.
  3. Овечкин А.М., Баялиева А.Ж., Ежевская А.А. и др. Послеоперационное обезболивание. Клинические рекомендации // Вестн. интенсив. тер. им. А.И.Салтанова. – 2019. – № 4. – C. 9–33
  4. Осипова Н.А., Береснев В.А., Петрова В.В. Мультимодальная системная фармакотерапия послеоперационного болевого синдрома // Consilium Medicum. – 2001. – Т. 3, № 9. – C. 432–438.
  5. Страчунский Л.С., Козлов С.Н. Нестероидные противовоспалительные средства: Метод. пособие. – Смоленск, 2009. – 54 с.
  6. Щеголев А.В. Лахин Р.Е., Грицай А.Н. Анестезиологическая и реаниматологическая помощь раненым // В кн.: Военно-полевая хирургия. Национальное руководство / Под ред. И.М.Самохвалова. – 2-е изд., перераб. и доп. – М.: ГОЭТАР-Медиа, 2024. – Гл. 9. – С. 249–305.
  7. Evidence based medicine consult. The mechanism of meperidine induced seizures and risk factors. URL:http://EBM Consult (дата обращения: 24.01.2024).
  8. Gillman P.K. Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity // Br. J. Anaesth. – 2005. – Vol. 95, N 4. – P. 434–441.
  9. Girard P., Chauvin M., Verleye M. Nefopam analgesia and its role in multimodal analgesia: A review of preclinical and clinical studies // Clin. Exp. Pharmacol. Physiol. – 2016. – Vol. 27, N 43. – P. 3–12.
  10. Kazuhiko Fukuda. Опиоиды // «Анестезия» Рональда Миллера: в 4 т. / Под ред. Р.Миллера; пер с англ. – СПб: Человек, 2015. – Т. 2, гл. 27. – С. 823–880.
  11. Kim K.H., Abdi S. Rediscovery of Nefopam for the Treatment of Neuropathic Pain // Korean J. Pain. – 2014. – Vol. 27, N 2. – P. 103–111.
  12. Meperidine Dosage. Medically reviewed by Drugs.com. Last updated on Aug 4, 2023. URL: http://Drugs.com (дата обращения: 24.01.2024).
  13. Military advanced regional anesthesia and analgesia handbook. – 2nd edition. – Oxford: University press, 2020. – 336 p.
  14. Nair A.S. Nefopam: Another Pragmatic Analgesic in Managing Chronic Neuropathic Pain // Indian J. Palliat. Care. – 2019. – Vol. 25, N 3. – P. 482–483.
  15. Rawal G., Kumar. R., Yadav S. et al. Pain management in intensive care unit: a brief review // Med. Res. Chronicles. – 2019. – Vol. 6, N 6. – P. 302–309.
  16. Schenk M., Wirz S. Serotonin syndrome and pain medication: What is relevant for practice // Schmerz. – 2015. – Vol. 29, N 2. – P. 229–251.

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig.1.

Download (113KB)

Copyright (c) 2024 Sergoventsev A.A., Shchegolev A.V., Chuprina A.P., Gritsai A.N., Arsentiev L.V., Aksenfeld D.I., Usoltsev E.A., Soloviev G.S.



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: № 01975 от 30.12.1992.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies